Literature DB >> 15290677

Primary paraganglioma of the lung.

Cheri L Aubertine1, Douglas B Flieder.   

Abstract

There are few reported cases of primary pulmonary paraganglioma in the pathology literature. Given the historical confusion surrounding bronchial tumors, widespread use of the term "chemodectoma" and classification of these lesions as paraganglioma in an outdated World Health Organization classification of lung tumors, the recognition of tumors arising from paraganglia within the lung has not been accepted by leading authorities. We present a well-documented case of a primary pulmonary paraganglioma with typical morphologic features and a supporting immunohistochemical profile. The 0.9 cm endobronchial tumor was submucosal and composed of nests of ovoid cells with abundant eosinophilic cytoplasm, cytoplasmic vacuoles, round to oval nuclei with speckled chromatin, and occasional conspicuous nucleoli. The nests of cells were surrounded by thin-walled vascular channels and stellate spindle cells. The ovoid cells showed strong diffuse staining for chromogranin A, synaptophysin, and faint staining for S-100; they were negative for cytokeratin AE1/AE3, Cam 5.2, and epithelial membrane antigen. The stellate spindle cells stained intensely positive for S-100 protein. A critical review of reported cases of pulmonary chemodectomas and paragangliomas in the English literature features few, if any, well-documented examples. While this exceedingly rare tumor should be discerned from carcinoid tumor, it remains unknown if primary pulmonary paragangliomas behave aggressively like intra-abdominal extra-adrenal paragangliomas, or in a more indolent manner observed with extra-adrenal paragangliomas in other locations.

Entities:  

Mesh:

Year:  2004        PMID: 15290677     DOI: 10.1053/j.anndiagpath.2004.04.008

Source DB:  PubMed          Journal:  Ann Diagn Pathol        ISSN: 1092-9134            Impact factor:   2.090


  7 in total

1.  Primary pulmonary paraganglioma: Two cases.

Authors:  Cabir Yüksel; Gökhan Kocaman; Bülent Mustafa Yenigün; Hilal Özakıncı; Serpil Dizbay Sak; Serkan Enön; Hakan Kutlay
Journal:  Turk Gogus Kalp Damar Cerrahisi Derg       Date:  2020-04-22       Impact factor: 0.332

2.  [S100 protein positive sustentacular cells in pulmonary carcinoids and thoracic paragangliomas: differential diagnostic and prognostic evaluation].

Authors:  A Warth; S Krysa; T Zahel; H Hoffmann; P Schirmacher; P A Schnabel; E Herpel
Journal:  Pathologe       Date:  2010-09       Impact factor: 1.011

3.  A case of endobronchial paraganglioma.

Authors:  P Muriana; A Bandiera; P Ciriaco; G Arrigoni; G Negri; P Zannini
Journal:  Ann R Coll Surg Engl       Date:  2016-09-23       Impact factor: 1.891

4.  Left subdiaphragmatic paraganglioma supplied by contralateral right renal artery.

Authors:  Jaime D Martinez; Benjamin Zendejas; Juan Pablo Sánchez Luna; Joseph Lopez; Sergio Sánchez Luna; Federico Mendoza-Sánchez; David R Farley
Journal:  Int J Surg Case Rep       Date:  2012-04-05

5.  Pulmonary paraganglioma manifesting as an endobronchial mass.

Authors:  Ki Nam Kim; Ki Nam Lee; Mee Sook Roh; Pil Jo Choi; Doo Kyung Yang
Journal:  Korean J Radiol       Date:  2008 Jan-Feb       Impact factor: 3.500

Review 6.  Data set for the reporting of pheochromocytoma and paraganglioma: explanations and recommendations of the guidelines from the International Collaboration on Cancer Reporting.

Authors:  Lester D R Thompson; Anthony J Gill; Sylvia L Asa; Roderick J Clifton-Bligh; Ronald R de Krijger; Noriko Kimura; Paul Komminoth; Ernest E Lack; Jacques W M Lenders; Ricardo V Lloyd; Thomas G Papathomas; Peter M Sadow; Arthur S Tischler
Journal:  Hum Pathol       Date:  2020-05-11       Impact factor: 3.466

7.  An incidentally discovered asymptomatic para-aortic paraganglioma with Peutz-Jeghers syndrome.

Authors:  Nazish Butt; Mohammad Salih; Mohammad Rizwan Khan; Rashida Ahmed; Zishan Haider; Syed Hasnain Ali Shah
Journal:  Saudi J Gastroenterol       Date:  2012 Nov-Dec       Impact factor: 2.485

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.